Pulmatrix, Inc. (PULM)
NASDAQ: PULM · Real-Time Price · USD
1.620
-0.050 (-2.99%)
At close: Jul 14, 2026, 4:00 PM EDT
1.500
-0.120 (-7.41%)
After-hours: Jul 14, 2026, 7:41 PM EDT
Pulmatrix Market Cap
Pulmatrix has a market cap or net worth of $5.92 million as of July 14, 2026. Its market cap has decreased by -76.86% in one year.
Market Cap
5.92M
Enterprise Value
2.59M
1-Year Change
-76.86%
Ranking
Category
Stock Price
$1.62
Market Cap Chart
Since June 16, 2015, Pulmatrix's market cap has decreased from $165.85M to $5.92M, a decrease of -96.43%. That is a compound annual growth rate of -25.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 5.92M | -27.35% |
| Dec 31, 2025 | 8.14M | -68.05% |
| Dec 31, 2024 | 25.49M | 275.27% |
| Dec 29, 2023 | 6.79M | -51.89% |
| Dec 30, 2022 | 14.12M | -42.64% |
| Dec 31, 2021 | 24.61M | -39.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioAtla | 6.48M |
| Addex Therapeutics | 6.32M |
| Processa Pharmaceuticals | 6.24M |
| Purple Biotech | 6.20M |
| Curanex Pharmaceuticals | 5.98M |
| Adial Pharmaceuticals | 5.84M |
| AIM ImmunoTech | 5.76M |
| Silo Pharma | 5.60M |